News
Archive
New Science Ventures announces merger of its portfolio company Achronix with ACE Convergence
NorthSea Therapeutics reports Positive Phase 2b interim results for icosabutate in NASH patients
Resolve Therapeutics announces clinically meaningful improvement in patients with Systemic lupus erythematosus in Phase 2a clinical trial
Resolve Therapeutics publishes positive Sjogren’s syndrome clinical trial results
NorthSea Therapeutics doses first patient in Phase 1 trial of SEFA-1024 in dyslipidemia and further expands its clinical pipeline
ProterixBio Announces Commercial Availability of a Semi-Quantitative COVID-19 Antibody Test
Back To News
July 23, 2019
All successful ETFs start with a good idea. But how do you know if you have a good idea?
Fuzzy Logix offers an automation tool called FastINDX to help ETF designers test drive their investment ideas. FastIndx is essentially a tool that allows someone who is in the market to design an ETF to first test out the pieces. In database analytics was created by performing the analytics directly where the data resides … Continue reading “All successful ETFs start with a good idea. But how do you know if you have a good idea?”
The post All successful ETFs start with a good idea. But how do you know if you have a good idea? appeared first on Fuzzy Logix.